Sapio Sciences has partnered with management consulting and technology company ZS to support digital laboratory deployments across biopharma R&D and chemistry, manufacturing, and controls environments.
The agreement combines Sapio Platform capabilities with ZS consulting and implementation services. Biopharma organisations deploying the platform will be able to access support for solution architecture, systems integration, change management, adoption, and validation.
ZS has joined the Sapio Partner Program as a consulting partner, with the collaboration focused on laboratory environments that require AI-ready, traceable data and governed workflows with human oversight. Those requirements are particularly pronounced in regulated R&D and CMC settings, where scientific flexibility has to be managed alongside data integrity, auditability, and compliance discipline.
The Sapio Platform brings together laboratory information management, electronic laboratory notebook, and scientific data management capabilities. Its role in a digital laboratory depends on more than record capture, because modern deployments must connect instruments, samples, methods, enterprise systems, quality processes, analytics tools, and scientific decision-making.
“Biopharma organizations are investing heavily in digital laboratories, particularly across development and CMC environments where data integrity and operational coordination are critical,” said Mike Hampton, Chief Commercial Officer, Sapio Sciences. “Partnering with ZS gives our customers access to deep life sciences consulting and systems integration expertise and through ZS’s global network, and helps us reach more organizations undertaking that journey.”
The partnership will cover R&D and discovery workflows, development and CMC laboratories, and broader laboratory informatics and data architecture. That includes integrating laboratory workflows with enterprise data environments, connecting systems with quality and regulatory processes, and designing scalable architectures that support analytics and AI initiatives.
Rohan Fernando, Managing Principal, Life Sciences R&D and Medical at ZS, said: “The need for results in R&D is extreme: speed, lower costs and higher success rates. ELN and LIMS systems are critical as modern science depends on AI-ready, traceable lab data to enable more effective collaboration and orchestration.”
Biopharma laboratory digitalisation has moved well beyond replacing paper records with electronic systems. Development, manufacturing, and quality teams increasingly need data infrastructure that preserves scientific context while supporting controlled automation, review, and reuse across regulated workflows.
CMC laboratories face a particularly narrow operating window because process development, analytical work, compliance evidence, and technology transfer often depend on the same underlying data. A deployment model that combines informatics software with implementation and validation support is therefore aimed at reducing the separation between laboratory operations and enterprise data strategy.
More information on the partnership is available from Sapio Sciences.
